Marex Group Beheer
Beheer criteriumcontroles 1/4
De CEO Marex Group is Ian Lowitt, benoemd in Jan2016, heeft een ambtstermijn van 10.5 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 17.27M, bestaande uit 7.6% salaris en 92.4% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 3.89% van de aandelen van het bedrijf, ter waarde $ 179.50M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 7 jaar en 2.5 jaar.
Belangrijke informatie
Ian Lowitt
Algemeen directeur
US$17.3m
Totale compensatie
| Percentage CEO-salaris | 7.63% |
| Dienstverband CEO | 10.5yrs |
| Eigendom CEO | 3.9% |
| Management gemiddelde ambtstermijn | 7yrs |
| Gemiddelde ambtstermijn bestuur | 2.5yrs |
Recente managementupdates
Recent updates
Narratiefupdate • Jul 23
MRX: Bermuda Move And Digital Collateral Shift Will Constrain Upside Potential
Analysts have raised their price target for Marex Group from $59.75 to $72.38, citing updated assumptions around revenue contraction, profit margin, and future P/E that together support a higher fair value estimate. What’s in the News for Marex Group Marex Group is allowing derivatives clients to post USDC stablecoin as initial margin collateral using Coinbase infrastructure, following a December 2025 CFTC no action letter that permits futures commission merchants to accept certain digital assets as margin.Narratiefupdate • Jul 08
MRX: Bermuda Redomiciliation Will Limit Future Upside From Current Levels
Analysts have nudged their price target for Marex Group higher from $57.13 to $59.75, citing updated assumptions that combine slightly softer revenue expectations with a small improvement in projected profit margins and a modestly higher future P/E multiple. What’s in the News for Marex Group Marex Group Limited completed its redomiciliation from England and Wales to Bermuda on July 1, 2026, following shareholder approval on May 21, 2026, and English High Court sanction on June 26, 2026.
Narratiefupdate • Jun 22
MRX: Higher Fair Value And Market Volatility Tailwinds Will Support Upside
Analysts have raised their price target for Marex Group from $66.00 to $75.00, citing updated assumptions around revenue trends, a slightly higher discount rate, and modestly adjusted profit margin and P/E expectations. What’s in the News for Marex Group Night Watch Investment Management identified Marex Group plc as its largest holding, highlighting the futures clearing business as critical financial infrastructure with a strong and defensible market position, and pointing to earnings that have grown roughly 7x over the past five years, according to recent commentary from the firm.Narratiefupdate • Jun 05
MRX: Levmet Deal And Bermuda Move Will Support Measured Future Upside
Analysts have maintained their $57.13 price target for Marex Group, reflecting steady assumptions for its discount rate, an expected revenue decline of 7.25%, a profit margin of 20.12% and a future P/E of 11.49x. What's in the News Marex Group agreed to acquire Levmet, a Monaco based liquidity provider focused on base and ferrous metals, energy, and power.Narratiefupdate • May 22
MRX: Q1 2026 Guidance And Dividend Outlook Will Support Measured Upside
Analysts have raised their price target for Marex Group from $55.00 to $57.13, citing updated assumptions on revenue trends, profit margins and future P/E expectations. What's in the News Marex Group plc issued earnings guidance for the first quarter of 2026, with expected revenue in a range of $667 million to $697 million for the period ended March 31, 2026, compared with Q1 2025 revenue of $467 million (Key Developments).Seeking Alpha • May 20
Marex Group: Strong Growth, Cheap Valuation, But Still A Volatility-Driven Story
Summary Marex Group plc (MRX) delivered strong Q1 results, with revenues up 48% and adjusted profit before tax up 59%, driven by volatility in energy and metals. MRX's forward P/E of 11.5x and high 22.1% operating margin position it attractively versus peers, despite a cyclical, volatility-dependent business model. Revenue diversification into clearing, securities, and solutions segments reduces reliance on commodities, but future growth remains sensitive to macroeconomic cycles. Key risks include interest rate declines, slower client balance growth, integration of WEBB Traders, and potential operational disruptions from the Bermuda headquarters move. Read the full article on Seeking AlphaNarratiefupdate • May 07
MRX: Higher Margins And Q1 2026 Outlook Will Support Measured Upside
Analysts have lifted Marex Group's price target from $50.29 to $55.00 as they now factor in a higher profit margin of about 20.9% and a lower future P/E of roughly 9.7, despite softer revenue growth assumptions and a slightly higher discount rate. What's in the News Marex Group issued earnings guidance for the first quarter ended March 31, 2026, with expected revenues in a range of $667 million to $697 million, compared with Q1 2025 revenues of $467 million (Key Developments).Narratiefupdate • Apr 22
MRX: Higher Fair Value And Lower Future P/E Will Support Upside
Analysts have lifted their fair value estimate for Marex Group from $61.00 to $66.00, citing updated assumptions for modest positive revenue growth, a slightly higher profit margin, and a lower future P/E of 11.40 compared with the prior 13.35. What's in the News Marex Group issued earnings guidance for the quarter ending March 31, 2026, with expected revenues in a range of $667 million to $697 million, compared with Q1 2025 revenues of $467 million (Key Developments).
Narratiefupdate • Apr 07
MRX: Rich Earnings Multiple Will Face Test From Softer Revenue Outlook
Analysts have inched their price targets for Marex Group higher by a few dollars into the mid $40s, reflecting updated views on revenue trends, margins, and a lower forward P/E assumption in recent TD Cowen, Piper Sandler, and Barclays research. Analyst Commentary Recent research reflects a mixed tone, with some optimism on Marex Group's revenue and margin outlook, alongside more cautious views on where the shares should trade relative to sector peers.Narratiefupdate • Mar 24
MRX: Volatility And Trading Volumes Will Test Fairly Priced Shares
Analysts have lifted their average price target on Marex Group by mid single digits. Recent moves include $7 and $5 increases, citing updated assumptions for revenue trends, profit margins, and a lower implied future P/E multiple despite a slightly higher discount rate.Narratiefupdate • Mar 09
MRX: Higher Trading Volumes And Supportive P/E Will Drive Future Upside
Analysts have lifted their average price target on Marex Group to $61, citing updated views on revenue trajectory, profit margins, and a modestly higher future P/E multiple informed by recent Street research revisions from TD Cowen, Piper Sandler, and Barclays. Analyst Commentary Bullish analysts are leaning into Marex Group's execution by lifting their individual price targets, which helps explain the higher Street average.Narratiefupdate • Feb 23
MRX: Rising Trading Volumes And Volatility Will Support Earnings Power
Narrative update on Marex Group Analysts have nudged their Marex Group price targets higher by $7 and $5 in recent updates, while one cut a target by $1 to $49. These changes reflect adjusted views on volumes, volatility, and earnings potential rather than a change to our $61 fair value estimate.Narratiefupdate • Feb 07
MRX: Higher Volatility And Volumes Will Support Earnings Power Going Forward
The analyst price target for Marex Group has increased from $56 to $61, with analysts citing updated views on revenue trends, profit margins, and future P/E assumptions reflected in recent research from TD Cowen, Piper Sandler, and Barclays. Analyst Commentary Recent research updates show bullish analysts lifting their fair value estimates for Marex Group, with the latest round of work incorporating refreshed views on revenue trends, margin resilience, and P/E assumptions.Narratiefupdate • Jan 23
MRX: US Expansion And Higher Trading Volumes Will Support Future Upside
Analysts have raised their price targets on Marex Group, reflecting a revised fair value estimate from $47.71 to $50.29 as they factor in updated expectations around volumes, revenue trends, margins, and future P/E assumptions following recent sector research. Analyst Commentary Recent research updates on Marex Group show a mix of optimism and caution as analysts refresh their models ahead of upcoming results and sector comparisons.Narratiefupdate • Jan 08
MRX: Rising Trading Activity Will Support Earnings Power Despite Slight Price Trim
Analysts have trimmed their price target on Marex Group to US$49 from US$50, citing refreshed views on sector volumes and volatility while keeping fair value and key valuation inputs broadly unchanged. Analyst Commentary Bullish analysts are treating the lower US$49 price target as a fine tuning rather than a reset, keeping their broader view on Marex Group intact while they refresh assumptions for sector activity.Narratiefupdate • Dec 23
MRX Will Benefit From Expanding US Structured Products And Margin Resilience
Analysts have trimmed their price target on Marex Group by 4 percent to $56.00, citing slightly higher discount rates and weaker revenue growth expectations, partly offset by improved profit margin forecasts and a more attractive forward earnings multiple. What's in the News Marex Group launched a US structured products business targeting RIAs, broker dealers, and private banks.Narratiefupdate • Dec 09
MRX: US Expansion Will Drive Future Upside Despite Pending Securities Lawsuits
Narrative Update on Marex Group Price Target Analysts have modestly reduced their averaged price target on Marex Group from approximately $49.00 to about $47.70. This reflects slightly weaker top line growth assumptions, partially offset by expectations for improved profit margins and a marginally lower future price to earnings multiple.Narratiefupdate • Nov 25
MRX: Diversified US Expansion Will Drive Recovery Despite Securities Lawsuit Risk
Analysts have raised their price target for Marex Group from $47.67 to $49.00, citing updated assumptions around profit margins and discount rates, which support a modestly higher valuation. What's in the News Marex Group has launched its structured products business in the United States, led by Scott Kerbel.Narratiefupdate • Nov 06
MRX: Revenue Outlook Will Support Rebound Despite Ongoing Class Action Lawsuits
Analysts have made a minor upward adjustment to the price target for Marex Group, now set at $47.67. This change is based on slight improvements in the revenue growth outlook and a stable discount rate.Narratiefupdate • Oct 23
Analysts Lower Marex Group Price Target Amid Accounting Allegations and Revised Profit Outlook
Analysts have slightly lowered their price target for Marex Group from $49.33 to $47.67. This change reflects recent updates to the company’s growth and profitability outlook.Narratiefupdate • Oct 08
Digitalization And M&A Will Unlock Global Market Potential
Analysts have lowered their price target for Marex Group from $50.89 to $49.33, citing slightly reduced profit margin forecasts and modestly improved revenue growth projections. What's in the News NINGI Research disclosed a short position in Marex Group, alleging the company used opaque off-balance-sheet entities, fictitious transactions, and misleading disclosures to obscure losses and inflate profits (Periodical).Analyse-artikel • Aug 06
Here's Why Marex Group (NASDAQ:MRX) Has Caught The Eye Of Investors
NasdaqGS:MRX 1 Year Share Price vs Fair Value Explore Marex Group's Fair Values from the Community and select yours...
Nieuw narratief • Apr 27
Acquisitions Will Fuel APAC And Middle East Expansion
Strong market share gains and acquisition integration are driving revenue growth and expanding product offerings and geographic reach.Analyse-artikel • Apr 10
Further Upside For Marex Group plc (NASDAQ:MRX) Shares Could Introduce Price Risks After 26% Bounce
Marex Group plc ( NASDAQ:MRX ) shareholders have had their patience rewarded with a 26% share price jump in the last...Analyse-artikel • Dec 25
Many Still Looking Away From Marex Group plc (NASDAQ:MRX)
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | US$334m |
| Dec 31 2025 | US$17m | US$1m | US$294m |
| Sep 30 2025 | n/a | n/a | US$266m |
| Jun 30 2025 | n/a | n/a | US$251m |
| Mar 31 2025 | n/a | n/a | US$234m |
| Dec 31 2024 | US$7m | US$1m | US$205m |
| Sep 30 2024 | n/a | n/a | US$189m |
| Jun 30 2024 | n/a | n/a | US$134m |
| Mar 31 2024 | n/a | n/a | US$140m |
| Dec 31 2023 | US$6m | US$1m | US$128m |
Compensatie versus markt: De totale vergoeding ($USD 17.27M ) Ian } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 6.99M ).
Compensatie versus inkomsten: De vergoeding van Ian is het afgelopen jaar met meer dan 20% gestegen.
CEO
Ian Lowitt (62 yo)
10.5yrs
Tenure
US$17,268,000
Compensatie
Mr. Ian Theo Lowitt has been Chief Executive Officer of Marex Financial (formerly known as Marex Financial Ltd) since 2016. He served as Executive Director at Marex Group PLC since November 01, 2012 until...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Group Chief Executive Officer | 10.5yrs | US$17.27m | 3.89% $ 179.5m | |
| Chief Financial Officer | 3.3yrs | US$2.27m | 0.013% $ 606.9k | |
| President | 7.1yrs | geen gegevens | 2.04% $ 94.1m | |
| Chief Technology Officer | 7.5yrs | geen gegevens | geen gegevens | |
| Head of Investor Relations | no data | geen gegevens | geen gegevens | |
| Head of Legal | 6.8yrs | geen gegevens | geen gegevens | |
| Group Head of Compliance | 4.4yrs | geen gegevens | geen gegevens | |
| Group Head of HR | no data | geen gegevens | geen gegevens | |
| Head of Institutional Sales | 10.1yrs | geen gegevens | geen gegevens | |
| Head of Business Development | 8.8yrs | geen gegevens | geen gegevens | |
| Chief Strategist & CEO of Capital Markets | 3.2yrs | geen gegevens | 1.78% $ 82.4m | |
| Chief Executive Officer of CSC Commodities | 6.6yrs | geen gegevens | geen gegevens |
7.0yrs
Gemiddelde duur
58.5yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van MRX is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Global Head of Energy & Director | no data | geen gegevens | geen gegevens | |
| Group Head of Risk & Director | no data | geen gegevens | geen gegevens | |
| Independent Chairman of the Board | 4.8yrs | US$518.79k | 0.044% $ 2.0m | |
| Independent Non-Executive Director | 2.5yrs | US$281.74k | 0.032% $ 1.5m | |
| Independent Non-Executive Director | less than a year | geen gegevens | 0.0029% $ 133.0k | |
| Independent Non-Executive Director | 4.8yrs | US$268.57k | 0.034% $ 1.5m |
2.5yrs
Gemiddelde duur
62yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van MRX wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.5 jaar), wat duidt op een nieuw bestuur.
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/07/24 03:32 |
| Aandelenkoers aan het einde van de dag | 2026/07/24 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Marex Group Limited wordt gevolgd door 11 analisten. 6 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Benjamin Budish | Barclays |
| Christopher Allen | Citigroup Inc |
| Alexander Blostein | Goldman Sachs |